98 related articles for article (PubMed ID: 1421445)
41. [Effect of eradication treatment on histological changes of the gastric mucosa in patients with non-ulcer dyspesia and Helicobacter pylori infection. Randomized prospective study].
Kyzeková J
Vnitr Lek; 1999 Feb; 45(2):90-6. PubMed ID: 15641227
[TBL] [Abstract][Full Text] [Related]
42. Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
Thong-Ngam D; Tangkijvanich P; Treeprasertsuk S; Wisedopas N; Kullavanijaya P
J Med Assoc Thai; 2002 Oct; 85(10):1054-9. PubMed ID: 12501895
[TBL] [Abstract][Full Text] [Related]
43. Eradication of helicobacter pylori among patients from a primary care practice.
Gomollón F; Gimeno L; Valdepérez J; Yus C; Marzo J; Pérez-Caballero MC
J Fam Pract; 1996 Dec; 43(6):551-5. PubMed ID: 8969702
[TBL] [Abstract][Full Text] [Related]
44. Gastric juice urease test and brushing urease test for Helicobacter pylori detection.
Vilaichone RK; Mahachai V; Tumwasorn S; Kullavanijaya P
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S74-8. PubMed ID: 12188455
[TBL] [Abstract][Full Text] [Related]
45. Campylobacter pylori in patients with dyspeptic symptoms and endoscopic evidence of erosion(s).
Elta GH; Murphy R; Behler EM; Barnett JL; Nostrant TT; Kern S; Appelman H
Am J Gastroenterol; 1989 Jun; 84(6):643-6. PubMed ID: 2729235
[TBL] [Abstract][Full Text] [Related]
46. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
[TBL] [Abstract][Full Text] [Related]
47. Weekend therapy for the treatment of Helicobacter pylori infection.
Tucci A; Poli L; Paparo GF; Bocus P; Togliani T; Mazzoni C; Orcioni GF; Agosti R; Grigioni WF; Sottili S; Caletti G
Am J Gastroenterol; 1998 May; 93(5):737-42. PubMed ID: 9625119
[TBL] [Abstract][Full Text] [Related]
48. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
[TBL] [Abstract][Full Text] [Related]
49. Helicobacter pylori eradication with doxycycline-metronidazole-bismuth subcitrate triple therapy.
Borody TJ; George LL; Brandl S; Andrews P; Lenne J; Moore-Jones D; Devine M; Walton M
Scand J Gastroenterol; 1992 Apr; 27(4):281-4. PubMed ID: 1589705
[TBL] [Abstract][Full Text] [Related]
50. Grading Helicobacter pylori gastritis in dyspeptic patients.
Alhomsi MF; Adeyemi EO
Comp Immunol Microbiol Infect Dis; 1996 Feb; 19(2):147-54. PubMed ID: 8814977
[TBL] [Abstract][Full Text] [Related]
51. Dental plaque: a permanent reservoir of Helicobacter pylori?
Desai HG; Gill HH; Shankaran K; Mehta PR; Prabhu SR
Scand J Gastroenterol; 1991 Nov; 26(11):1205-8. PubMed ID: 1754858
[TBL] [Abstract][Full Text] [Related]
52. Antral nodularity, gastric lymphoid hyperplasia, and Helicobacter pylori in adults.
Sbeih F; Abdullah A; Sullivan S; Merenkov Z
J Clin Gastroenterol; 1996 Apr; 22(3):227-30. PubMed ID: 8724265
[TBL] [Abstract][Full Text] [Related]
53. Eradication of Helicobacter pylori and long-term outcome of functional dyspepsia. A clinical endoscopic study.
Lazzaroni M; Bargiggia S; Sangaletti O; Maconi G; Boldorini M; Bianchi Porro G
Dig Dis Sci; 1996 Aug; 41(8):1589-94. PubMed ID: 8769284
[TBL] [Abstract][Full Text] [Related]
54. Helicobacter pylori infection and non-ulcer dyspepsia: the effect of treatment with colloidal bismuth subcitrate.
Goh KL; Parasakthi N; Peh SC; Wong NW; Lo YL; Puthucheary SD
Scand J Gastroenterol; 1991 Nov; 26(11):1123-31. PubMed ID: 1754846
[TBL] [Abstract][Full Text] [Related]
55. Histology compared with chemical testing for urease for rapid detection of Helicobacter pylori in gastric biopsy specimens.
Zaitoun AM
J Clin Pathol; 1993 Jul; 46(7):684-5. PubMed ID: 8157765
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of 13C-urea breath test in the detection of Helicobacter pylori and in monitoring the effect of tripotassium dicitratobismuthate in non-ulcer dyspepsia.
Dill S; Payne-James JJ; Misiewicz JJ; Grimble GK; McSwiggan D; Pathak K; Wood AJ; Scrimgeour CM; Rennie MJ
Gut; 1990 Nov; 31(11):1237-41. PubMed ID: 2253905
[TBL] [Abstract][Full Text] [Related]
57. Bismuth subsalicylate suppression of Helicobacter pylori in nonulcer dyspepsia: a double-blind placebo-controlled trial.
Marshall BJ; Valenzuela JE; McCallum RW; Dooley CP; Guerrant RL; Cohen H; Frierson HF; Field LG; Jerdack GR; Mitra S
Dig Dis Sci; 1993 Sep; 38(9):1674-80. PubMed ID: 8359080
[TBL] [Abstract][Full Text] [Related]
58. Nonsteroidal antiinflammatory drugs could reverse Helicobacter pylori-induced apoptosis and proliferation in gastric epithelial cells.
Zhu GH; Yang XL; Lai KC; Ching CK; Wong BC; Yuen ST; Ho J; Lam SK
Dig Dis Sci; 1998 Sep; 43(9):1957-63. PubMed ID: 9753258
[TBL] [Abstract][Full Text] [Related]
59. Non-ulcer dyspepsia and short term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori.
Rokkas T; Pursey C; Uzoechina E; Dorrington L; Simmons NA; Filipe MI; Sladen GE
Gut; 1988 Oct; 29(10):1386-91. PubMed ID: 3058555
[TBL] [Abstract][Full Text] [Related]
60. Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study.
Kang JY; Tay HH; Wee A; Guan R; Math MV; Yap I
Gut; 1990 Apr; 31(4):476-80. PubMed ID: 2186982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
